Cowen & Co Downgrades Alpharma (ALO) to Neutral on Acquisition Offer From King
Tweet Send to a Friend
Cowen & Co downgrades Alpharma (NYSE: ALO) from Outperform to Neutral.
Cowen analyst says, "With Alpharma shares ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Cowen analyst says, "With Alpharma shares ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
